These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 11128531)

  • 1. Thoughts on vaccination protocols.
    Petzel B
    J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
    [No Abstract]   [Full Text] [Related]  

  • 2. Thoughts on vaccination protocols.
    McLaughlin MA
    J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
    [No Abstract]   [Full Text] [Related]  

  • 3. Opposing views of revaccination strategies.
    Palmquist R
    J Am Vet Med Assoc; 2000 Dec; 217(12):1789-91. PubMed ID: 11132877
    [No Abstract]   [Full Text] [Related]  

  • 4. Canine parvovirus vaccination.
    Atkinson M
    Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
    Coyne MJ
    J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenge studies for registration of canine core vaccines: is it time to update the European Pharmacopeia?
    Decaro N; Elia G; Buonavoglia C
    Vet Microbiol; 2020 May; 244():108659. PubMed ID: 32402341
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
    Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
    BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questions regarding revaccination protocols.
    Land AE
    J Am Vet Med Assoc; 2001 Feb; 218(4):505. PubMed ID: 11229492
    [No Abstract]   [Full Text] [Related]  

  • 15. Serologic response of maned wolves (Chrysocyon brachyurus) to canine and canine parvovirus vaccination distemper virus.
    Maia OB; Gouveia AM
    J Zoo Wildl Med; 2001 Mar; 32(1):78-80. PubMed ID: 12790399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a dot enzyme-linked immunosorbent assay for evaluation of the immune status to canine parvovirus and distemper virus in adult dogs before revaccination.
    Waner T; Mazar S; Keren-Kornblatt E
    J Vet Diagn Invest; 2006 May; 18(3):267-70. PubMed ID: 16789715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vaccination against canine parvovirus.
    Thompson H
    Vet Rec; 2006 Oct; 159(17):570-1; discussion 571. PubMed ID: 17056657
    [No Abstract]   [Full Text] [Related]  

  • 19. Duration of antibodies elicited by canine distemper virus vaccinations in dogs.
    Olson P; Finnsdóttir H; Klingeborn B; Hedhammar A
    Vet Rec; 1997 Dec 20-27; 141(25):654-5. PubMed ID: 9466386
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.